argus

Mankind Pharma Limited

NSE: MANKINDINE634S0102897,467 Cr

Timeline

Time (IST)TypeMEventSrc
03 Feb, 04:20 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
03 Feb, 04:19 pmMankind Pharma Limited has informed the Exchange regarding a press release dated February 03, 2026, titled "Financial Results Q3FY26".nse
03 Feb, 04:18 pmMankind Pharma Ltd - 543904 - Board Meeting Outcome for Outcome Of Board Meeting Of Financial Results For Q3 FY26bse
03 Feb, 04:14 pmMankind Pharma Ltd - 543904 - Financial Result For The Quarter And Nine Months Ended December 31, 2025bse
03 Feb, 04:13 pmMankind Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
16 Jan, 06:27 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
16 Jan, 06:25 pmMankind Pharma Limited has informed the Exchange about Credit Ratingnse
09 Jan, 11:53 amMankind Pharma Ltd - 543904 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Companybse
10 Dec, 06:30 pmMankind Pharma Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 (Listing Regulations)nse
10 Dec, 01:47 pmMankind Pharma Ltd - 543904 - Intimation Regarding ESG Ratingbse
10 Dec, 01:45 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
28 Nov, 04:38 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
28 Nov, 04:38 pmMankind Pharma Ltd - 543904 - Intimation Regarding ESG Ratingbse
26 Nov, 04:36 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Allotmentbse
16 Nov, 03:22 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
16 Nov, 03:13 pmMankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015bse
15 Nov, 02:19 pmMankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
15 Nov, 02:12 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
13 Nov, 09:29 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
13 Nov, 09:26 pmMankind Pharma Limited has informed the Exchange about Credit Ratingnse
11 Nov, 06:01 pmMankind Pharma Limited has informed the Exchange about Transcriptnse
11 Nov, 05:49 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
06 Nov, 09:33 pmMankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
06 Nov, 08:00 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
06 Nov, 07:51 pmMankind Pharma Limited has informed the Exchange about Link of Recordingnse
06 Nov, 04:44 pmMankind Pharma Limited has informed the Exchange about Investor Presentationnse
06 Nov, 04:44 pmMankind Pharma Limited has informed the Exchange regarding Board meeting held on November 06, 2025.nse
06 Nov, 04:43 pmMankind Pharma Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Press Release for Q2FY26".nse
06 Nov, 04:38 pmIntimation of participation in the Annual Investor Conference organized by Avendus Spark on November 12, 2024 at Mumbainse
06 Nov, 04:38 pmMankind Pharma Ltd - 543904 - Financial Results For The Quarter And Half Year Ended 30Th September 2025bse
06 Nov, 04:32 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
06 Nov, 04:30 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
06 Nov, 04:29 pmMankind Pharma Ltd - 543904 - Board Meeting Outcome for Outcome Of Board Meetingbse
04 Nov, 10:51 pmMankind Pharma Ltd - 543904 - Intimation Regarding ESG Ratingbse
04 Nov, 10:49 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
29 Oct, 10:16 pmMankind Pharma Ltd - 543904 - Intimation Regarding ESG Ratingbse
29 Oct, 10:02 pmMankind Pharma Limited has informed the Exchange about ESG Ratingnse
29 Oct, 06:06 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
29 Oct, 06:06 pmMankind Pharma Limited has informed the Exchange about Credit Ratingnse
27 Oct, 06:24 pmMankind Pharma Ltd - 543904 - Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended On September 30, 2025bse
10 Oct, 04:27 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
10 Oct, 04:24 pmMankind Pharma Limited has informed the Exchange about Acquisitionnse
10 Sept, 10:34 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
10 Sept, 10:33 pmMankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
02 Sept, 06:01 pmIntimation of receipt of approval for reclassification of Ayushi and Poonam Estates LLP from Promoter & Promoter Group to Public Category ofMankind Pharma Limitednse